Literature DB >> 17495437

Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy.

Marc Buren1, Michifumi Yamashita, Yusuke Suzuki, Yasuhiko Tomino, Steven N Emancipator.   

Abstract

Defective adaptive humoral immune responses to mucosal immunogens, but intact systemic responses, are increasingly recognized in patients with IgA nephropathy (IgAN). Reduced expression of IgA+, J chain+ cells in the gut lamina propria, with collateral increases in these cells in the marrow, is also documented. Thus, there seems to be a derangement in a 'mucosa-marrow axis' in IgAN patients. Recent evidence indicates that chemokines regulate the localization of B cells and their progeny into respiratory and intestinal lamina propria, and into other lymphoid organs as well. Particularly, secretory epithelial cells express the chemokine CCL28, whereas small bowel cells uniquely express CCL25. Extramucosal sites preferentially express CXCL12, CXCL13 and/or CXCL16. Reciprocally, plasmablasts committed to IgA synthesis ubiquitously express the receptor (CCR10) for CCL28, and a subset also express the receptor (CCR9) for CCL25; neither of these is present on cells committed to IgG or IgM synthesis. Herein, the potential contributions of virally induced innate responses to defective mucosal immunity and overproduction of oligomeric IgA in the marrow and tonsils will be reviewed, particularly with respect to the influence that viral infection exerts upon the expression of selected chemokine and receptor pairs. The ramifications for pathogenesis of IgAN will be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495437     DOI: 10.1159/000102304

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  11 in total

Review 1.  Secondary IgA nephropathy.

Authors:  Manish K Saha; Bruce A Julian; Jan Novak; Dana V Rizk
Journal:  Kidney Int       Date:  2018-05-24       Impact factor: 10.612

Review 2.  IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Authors:  Arun Rajasekaran; Bruce A Julian; Dana V Rizk
Journal:  Am J Med Sci       Date:  2020-10-08       Impact factor: 2.378

Review 3.  IgA glycosylation and immune complex formation in IgAN.

Authors:  Hitoshi Suzuki; Jan Novak
Journal:  Semin Immunopathol       Date:  2021-09-27       Impact factor: 9.623

4.  B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.

Authors:  Senka Sendic; Ladan Mansouri; Sigrid Lundberg; Anna Nopp; Stefan H Jacobson; Joachim Lundahl
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

Review 5.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

Review 6.  New insights into the pathogenesis of IgA nephropathy.

Authors:  See Cheng Yeo; Chee Kay Cheung; Jonathan Barratt
Journal:  Pediatr Nephrol       Date:  2017-06-17       Impact factor: 3.714

Review 7.  What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection.

Authors:  Yue-Miao Zhang; Xu-Jie Zhou; Hong Zhang
Journal:  Kidney Int Rep       Date:  2017-02-14

8.  Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study.

Authors:  Tong-Dan Bi; Jian-Nan Zheng; Jun-Xiao Zhang; Long-Shu Yang; Nan Liu; Li Yao; Lin-Lin Liu
Journal:  BMC Nephrol       Date:  2019-07-04       Impact factor: 2.388

Review 9.  The Role of Immune Modulation in Pathogenesis of IgA Nephropathy.

Authors:  Sheng Chang; Xiao-Kang Li
Journal:  Front Med (Lausanne)       Date:  2020-03-24

Review 10.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.

Authors:  Jia-Wei He; Xu-Jie Zhou; Ji-Cheng Lv; Hong Zhang
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.